Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phagolysosomal pH modulation is the process by which cells regulate the acidity inside phagolysosomes, organelles formed by the fusion of phagosomes and lysosomes. Acidification is achieved mainly by ATP-driven proton pumps called V-ATPases, which lower the pH to 4.5–5.0, creating an environment optimal for the degradation of ingested pathogens or debris. pH regulation is crucial for activating hydrolytic enzymes, microbial killing, antigen processing, and host-pathogen interactions. Imbalances in phagolysosomal acidification can allow some pathogens to evade destruction or impair antigen presentation, impacting immunity and infection outcomes. Targeting this process is not typical in drug development, but some experimental and clinical agents (e.g., chloroquine) alter phagosomal/lysosomal pH indirectly. In summary: "Phagolysosomal pH modulation" is not a single molecule, receptor, or protein but refers to a process involving many proteins (most notably, V-ATPase), ion channels, and regulators. It should not be treated as a canonical drug target.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phagolysosomal pH modulation (null).